Article
Author(s):
BCAN’s Young Investigator Awards support outstanding early-career scientists and clinical cancer researchers with a demonstrated commitment to improving the understanding and treatment of bladder cancer and/or upper tract urothelial cancer. Applicants may be working in basic, translational, clinical, epidemiologic, bioengineering sciences or any other field, but projects must be specific to bladder cancer and/or upper tract urothelial carcinoma, and the applicant’s research environment must be capable of supporting transformational bladder cancer research.
Applicants must have a mentor within or approved by the sponsoring institution that will assume responsibility for the overall conduct of the project and provide guidance and protected research time.
What is the Patient-Centered Clinical Research Young Investigator Award?
The Patient-Centered Clinical Research Young Investigator Award (PCC-YIA) supports early-career scientists and clinical cancer researchers investigating transformational patient-oriented clinical bladder cancer and/or upper tract urothelial cancer research (e.g. studies of shared decision making, access to care, quality of care, quality of life, health disparities, comparative effectiveness research, patient-centered outcomes research, and survivorship).
Applicants must have a mentor within or approved by the sponsoring institution that will assume responsibility for the overall conduct of the project and provide guidance and protected research time.
Project Period: 1 year
Total Funding: $75,000; Indirect costs are not allowable
Guidelines for Young Investigator Award
Guidelines for Patient-Centered Clinical Research
MEET OUR FUNDED YOUNG INVESTIGATORS
Contact us at grants@bcan.org.
More information
Learn more about the Bladder Cancer Advocacy Network’s research grant program as well as additional funding opportunities.